510(k) device
pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy Device
Phenox Limited · Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL, Class II) · First FDA decision Feb 28, 2025, newest Feb 28, 2025Acute ischemic stroke
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
8
Naming "pRESET Delta"
MAUDE reports
2
Brand "pRESET Delta", since 2015
PubMed studies
2
Mentioning "pRESET Delta"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K242676 · Decided Feb 28, 2025 · 175 days after receipt
Device type: Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "pRESET Delta", any status and sponsor, newest update first.
Shenyang Medical CollegeAcademic, hospital or other
NCT07244484 · 56 participants (planned) · Start Nov 23, 2025 · Primary completion May 23, 2026
Device: Real-time fNIRS-based neurofeedback · For: Coronary Heart Disease (CHD); Anxiety Disorders
Sites: Shenyang, China
Fayoum University HospitalAcademic, hospital or other
NCT05980494 · 150 participants · Start Sep 13, 2022 · Primary completion May 20, 2024
Device: lung ultrasound; inferior vena cava measurements and 1 more · For: Sepsis; Critical Illness
Sites: Al Fayyum, Egypt
- Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic RhinitisPivotal-lookingCompleted
Chordate MedicalNot on our public-company list
NCT03399721 · 279 participants · Start May 7, 2018 · Primary completion Sep 30, 2022
Device: Chordate S101; Chordate S101 Placebo · For: Nasal Congestion; Non-allergic Rhinitis
Sites: Hradec Králové, Czechia; Pardubice, Czechia; Prague, Czechia · 13 sites in all
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "pRESET Delta", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 2 injury, 0 death
Whole product code POL
97 reports: 40 malfunction, 55 injury, 2 death
Newest reports for this brand
3013656790-2026-00002 · Received May 27, 2026
Device type: Catheter, Thrombus Retriever (NRY)
Device problem as coded: Material Separation
Patient problem as coded: Stroke/CVA
3013656790-2026-00003 · Received May 27, 2026
Device type: Catheter, Thrombus Retriever (NRY)
Device problem as coded: Material Separation
Patient problem as coded: Stroke/CVA
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "pRESET Delta"[tiab]. The summary above synthesizes these.
- Na/H- and Cl/OH-exchange in rat jejunal and rat proximal tubular brush border membrane vesicles. Studies with acridine orange.
Cassano G, Stieger B, Murer H · Pflugers Arch · 1984Research Support, Non-U.S. Gov't
- Comparison of Na+/H+ and Cl-/OH- exchange in rat jejunal brush border membrane vesicles: studies with acridine orange.
Cassano G, Murer H · Boll Soc Ital Biol Sper · 1984
Other devices of this type
Also filed under product code POL.
- Trevo NXT ProVue RetrieverStryker Neurovascular · 510(k) 2023
- Trevo NXT ProVue RetrieverStryker · 510(k) 2020
- Solitaire 2 Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2019
- pRESET LITE Thrombectomy DevicePhenox Limited · 510(k) 2023
- pRESET Thrombectomy DevicePhenox Limited · 510(k) 2023
- Solitaire X Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2021
- Trevo XP ProVue Retriever and Trevo NXT ProVue RetrieverStryker Neurovascular · 510(k) 2020
- Solitaire Platinum Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.